跳至主要内容
临床试验/NCT03801135
NCT03801135Unknown不适用

A Prospective Interventional Study to Investigate Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation With or Without Coagulation Factors Replacement

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年10月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
20
试验地点
1
主要终点
Effect of plasmapheresis replacement fluid type on fibrinogen level

研究概览

简要总结

Plasma exchange procedures remove procoagulant and anticoagulant factors. Every procedure increases the risk of bleeding and repeated procedures increase the risk of bleeding mostly because lower fibrinogen levels. The aim of study is to define coagulation status of patient after plasmapheresis with different laboratory tests and to investigate the possibility of fibrinogen concentrate replacement for the correction of induced coagulation disorder.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Every patient who will need repeated plasmapheresis treatment in UKC Ljubljana

排除标准

  • pregnancy
  • coagulation disorders
  • Hypertriglyceridemia-induced acute pancreatitis
  • hepatic disorders

研究组 & 干预措施

Fibrinogen Treatment Group

Experimental

One calculated plasma volume will be replaced with a mixture of electrolyte replacement solution and albumin. Fibrinogen concentrate will be infused afterwards.

干预措施: Fibrinogen concentrate (Drug)

FFP Treatment Group

Active Comparator

One calculated plasma volume will be replaced with a mixture of electrolyte replacement solution, albumin and fresh frozen plasma.

干预措施: Fresh Frozen Plasma (Other)

结局指标

主要结局

Effect of plasmapheresis replacement fluid type on fibrinogen level

时间窗: Right after every plasmapheresis session, during the whole plasmapheresis treatment (usually about 2 weeks)]

Change of fibrinogen level after plasmapheresis treatment depending on replacement fluid type

次要结局

  • Effect on coagulation tests after plasmapheresis - ROTEM EXTEM(Right after every plasmapheresis session, during the whole plasmapheresis treatment (usually about 2 weeks)])
  • Effect on coagulation tests after plasmapheresis - ROTEM FIBTEM(Right after every plasmapheresis session, during the whole plasmapheresis treatment (usually about 2 weeks)])

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Matej Zrimsek

Principal Investigator

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验